CureMatch Announces New Advances in Using Metabolomic Profiling to Distinguish Among Cancer Subtypes
This Discovery is Expected to Pave the Way for Metabolomic Profiling in the Monitoring and Treatment of Cancer SAN DIEGO, CA – February 23, 2017 – CureMatch, the developer of a decision support platform for combination therapy in cancer, revealed in the 2nd Annual Biomarker Conference new discoveries using metabolomics as a tool for clinical […]